Description

Lysigin® is a lysed culture of highly antigenic polyvalent somatic antigen containing phage types I, II, III, IV and miscellaneous groups of Staph aureus.

Features

Extensively tested in controlled studies and in field studies.

Contains five different phage types of Staph aureus.

Includes capsular serotypes 5, 8, 336.

Benefits

Up to three times higher spontaneous cure rates over cows receiving no vaccine.

Reduces chronicity of infection when a vaccination program starts at an early age.

Allows cows opportunity to reach their genetic potential for milk production.

Reduces culling.

Advantages

Lysigin is produced from five phage types of Staph aureus and includes capsular serotypes 5, 8, 336.

Dosage & Administration

Using aseptic technique inject a single 5 mL dose IM in cattle. Repeat in 14 days. Follow with a single 5 mL booster dose each 5 to 6 months. Start vaccinating all heifers at 6 months of age.

Precautions

Store out of direct sunlight at a temperature between 35° - 45° F (2° - 7° C). Avoid freezing. Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur.
Antidote: Epinephrine.

Uses

Lysigin is recommended for vaccination of healthy, susceptible cattle against mastitis caused by Staph aureus.

Warning

Highlights

- Contains five different phage types of Staph aureus.

- Includes capsular serotypes 5, 8, 336.

- Efficacy tested and proved in controlled and field studies.

Packaging Options (top)

Contact Information For LYSIGIN® (top)

Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway
St. Joseph, MO 64506
800-821-7467 Information
800-325-9167 Sales
816-236-2717
email: judith.sprague@boehringer-ingelheim.com
internet: http://www.bi-vetmedica.com

General Product Information Documents (top)

Product Image for LYSIGIN® (top)

Related Technical Bulletins (top)